Bleichmar Fonti & Auld LLP & Illumina — Holy Grail

Bleichmar Fonti & Auld LLP: Bleichmar Fonti & Auld LLP is one of the law firms that filed the class action lawsuit against Illumina — Holy Grail, representing investors.

Illumina — Holy Grail: Illumina — Holy Grail is the defendant in the securities class action; its stock dropped over 50% after the NHS-Galleri trial failed to meet its primary endpoint, resulting in a $2.2 billion market cap loss.

Bleichmar Fonti & Auld LLP: BFA filed a class action lawsuit against Illumina — Holy Grail and certain executives, alleging securities fraud related to the NHS-Galleri trial. The firm is actively soliciting investors to join the case.

Illumina — Holy Grail: Illumina — Holy Grail is the defendant in multiple securities fraud class actions. The company's stock collapsed 50.55% after its NHS-Galleri trial failed to meet its primary endpoint, erasing over $2.2 billion in market capitalization. The litigation and trial failure severely damage its financial standing and investor trust.